A Clinical Study to Evaluate the Effectiveness of a Novel Portable Non-Pneumatic Active Compression Device vs. an Advanced Pneumatic Compression Device for Treating Lower Extremity Lymphedema

Last updated: March 21, 2024
Sponsor: Koya Medical, Inc.
Overall Status: Completed

Phase

N/A

Condition

Varicose Veins

Stasis Dermatitis

Deep Vein Thrombosis

Treatment

Cross over Device (PCD or Dayspring - alternate to first group)

Clinical Study ID

NCT05507346
KCT 009 (TEAYS)
  • Ages 18-100
  • All Genders

Study Summary

To evaluate the Koya wearable device - a Novel Portable Non-Pneumatic Active Compression Device (NPCD) in contrast to an advanced pneumatic compression device (APCD)

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Males and females ≥ 18 years of age
  • Capable and willing to sign the informed consent and deemed capable of following thestudy protocol
  • Subjects must have a diagnosis of primary or secondary unilateral or bilateral lowerextremity edema or lower extremity phlebolymphedema from chronic venous insufficiency

Exclusion

Exclusion Criteria:

  • Individuals with a history or presence of a systemic disorder or condition that couldplace the subject at increased risk from sequential compression therapy
  • Inability or unwillingness to participate in all aspects of study protocol and/orinability to provide informed consent
  • Subjects with exam results that would prevent safe and effective use of the studydevice (cellulitis, open-wounds, healing-wounds, etc.)
  • Subjects must not have any diagnosed cognitive or physical impairment that wouldinterfere with use of the device
  • Individuals who present with Ankle-brachial Index (ABI) screening score < 0.8 and > 1.30, indicating the possibility of Peripheral Arterial disease (PAD)
  • Diagnosis of lipedema
  • Diagnosis of active or recurrent cancer (< 3 months since completion of chemotherapy,radiation therapy or primary surgery for the cancer)
  • Diagnosis of acute infection (in the last four weeks)
  • Diagnosis of acute thrombophlebitis (in last 6 months)
  • Diagnosis of pulmonary embolism or deep vein thrombosis within the previous 6 months
  • Diagnosis of pulmonary edema
  • Diagnosis of congestive heart failure (uncontrolled/uncompensated)
  • Diagnosis of chronic kidney disease with acute renal failure
  • Diagnosis of epilepsy
  • Subjects with poorly controlled asthma
  • Any condition where increased venous and lymphatic return is undesirable
  • Women who are pregnant, planning a pregnancy or nursing at study entry
  • Participation in any clinical trial of an investigational substance or device duringthe past 30 days

Study Design

Total Participants: 121
Treatment Group(s): 1
Primary Treatment: Cross over Device (PCD or Dayspring - alternate to first group)
Phase:
Study Start date:
September 06, 2022
Estimated Completion Date:
January 09, 2024

Study Description

A Multi-center Randomized Control Single Cross-over Study to Evaluate the Safety and Effectiveness of Dayspring, a Novel Portable Non-Pneumatic Active Compression Device (NPCD) vs. an Advanced Pneumatic Compression Device (APCD) for Treating Lower Extremity Lymphedema. To evaluate the Dayspring, a Novel Portable Non-Pneumatic Active Compression Device (NPCD) in contrast to an advanced pneumatic compression device (APCD) in a multi-centered setting to evaluate volume, quality of life, safety, adherence, and preference.

Connect with a study center

  • Stanley G Rockson

    Oakland, California 94607
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.